Photo: "Tokyo Stock Exchange" by Dick Thomas Johnson, BY via Openverse
Single-Stock Futures Died in 2020. CME Thinks the SpaceX IPO Squeeze Just Brought Them Back to Life
A product that Wall Street already tried and abandoned once is getting a second chance, built on a frustration a lot of retail traders know firsthand: watching a hot IPO price and getting nothing.
The clearest example this year has been SpaceX. When shares of buzzy private companies do reach the public markets, allocations to individual investors are typically thin to nonexistent — most of the stock goes to institutions before retail ever gets a look. That scarcity is part of the bet behind CME Group's decision to relaunch single-stock futures on Monday, more than two decades after the exchange's first attempt at the product collapsed. The new contracts, covering more than 50 of the largest U.S. companies including Nvidia, will let investors take a leveraged long or short position on a stock's closing price — without owning a share of it and, notably, without needing to buy in at an IPO price they were never offered in the first place.
The mechanics are built to route around the two things that historically kept retail traders out of this kind of leverage: complexity and access. The contracts are cash-settled, meaning no shares change hands, and CME is pitching them as a way to get options-like leverage without options' pricing math — no Greeks, no implied volatility curves to model. They'll trade five days a week for 23 hours a day, well beyond the standard 9:30-to-4 equity session, in two sizes: 55 standard contracts tied to 100 shares each, and 22 "micro" contracts tied to just 10 shares, covering the Magnificent Seven plus names like Micron, Pfizer, and Walmart. CME has also recruited more than 35 retail brokerages to distribute them.
What actually failed the first time is worth being specific about, because CME's own explanation — CEO Terry Duffy's line that "the world has evolved since 2000" — is more assertion than evidence on its own. In 2002, retail options trading was a niche activity, payment-for-order-flow hadn't yet made stock and options trades free, and the number of U.S. public companies was still near its peak, so there was little unmet appetite for synthetic stock exposure. Today, all three conditions have flipped: the pool of public companies has shrunk for two decades as more firms stay private longer, retail options volume has become a routine part of app-based trading, and a company like SpaceX can command a private valuation in the hundreds of billions while ordinary investors have no direct way in. That combination — more demand for exposure to companies retail can't easily buy, and a retail base already comfortable with derivatives — is the actual argument for why this might work now, beyond CME simply asserting that it will.
The open question is distribution, not appetite. Options and stock trades are typically commission-free for retail investors because brokers get paid through order flow; futures traders generally still pay commissions, a real cost retail has grown unaccustomed to. As Citigroup's Stuart Kaiser put it, breaking retail's habit of sourcing leverage through call options and levered ETFs will likely depend on whether discount brokers actively push the new contracts — not on the product's mechanics alone. Trading outside normal market hours, including in the volatile minutes after earnings, also carries its own risks, according to the Options Clearing Corp.'s Mat Cashman. CME has regulatory approval and a broker network in place; whether retail traders actually show up is the part still unproven.